作者: Yarely M. Salinas-Vera , Laurence A. Marchat , Raúl García-Vázquez , Claudia Haydée González de la Rosa , Eduardo Castañeda-Saucedo
DOI: 10.1016/J.CANLET.2018.06.003
关键词: MAPK/ERK pathway 、 Cancer research 、 Proto-oncogene tyrosine-protein kinase Src 、 Transduction (genetics) 、 Vasculogenic mimicry 、 Protein kinase B 、 Signal transduction 、 PI3K/AKT/mTOR pathway 、 Biology 、 Phosphorylation
摘要: Abstract RNA-based multi-target therapies focused in the blocking of signaling pathways represent an attractive approach cancer. Here, we uncovered a miR-204 cooperative targeting multiple transducers involved vasculogenic mimicry (VM). Our data showed that invasive triple negative MDA-MB-231 and Hs-578T breast cancer cells, but not poorly MCF-7 cells, efficiently undergoes matrix-associated VM under hypoxia. Ectopic restoration MDA-MB-231 cells leads to potent inhibition reduction number branch points patterned 3D channels. Further analysis activation state using Phosphorylation Antibody Arrays revealed reduced expression phosphorylation levels 13 proteins PI3K/AKT, RAF1/MAPK, VEGF, FAK/SRC signaling. In agreement with phospho-proteomic profiling, was impaired following pharmacological administration PI3K SRC inhibitors. Mechanistic studies confirmed exerts post-transcriptional regulation PI3K-α c-SRC proto-oncogenes. Moreover, overall survival large cohort patients indicates low high were associated worst outcomes. conclusion, our study provides novel lines evidence indicating may fine-tuning synergistic transduction PI3K/AKT/FAK mediators critical formation.